Pre-existing anti-SARS-CoV-2 immunity decreases viral spread but increase SARS-CoV-2 Omicron competitiveness in hamsters
Por um escritor misterioso
Descrição
In a new study, researchers assessed the impact of pre-existing immunity against SARS-CoV-2 acquired by previous infections (PI) or COVID-19 vaccination on the transmission of SARS-CoV-2 variants of concern such as Delta and Omicron.
The impact of pre-existing cross-reactive immunity on SARS-CoV-2
Immune response in COVID-19: what is next?
Vaccines, Free Full-Text
Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2
SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease
Innate and adaptive immune responses to SARS-CoV-2 infection in
COVID-19 Pandemic: Insights into Interactions between SARS-CoV-2
Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
de
por adulto (o preço varia de acordo com o tamanho do grupo)
